Update: Anti‐Amyloid Treatments for Alzheimer's Disease: Patients’ and Families’ Perception and Experience with Drug Consultation

Drug consultation with a behavioral neurologist on the new Alzheimer's Disease therapies serves as an important decision-making aid for patients and families when considering AATs- identifying concerns and ensuring understanding of risks, benefits and overall impact of taking these newly available treatments. We plan to do additional data analysis to evaluate whether demographic factors, such as age, play a role in decision-making.